Cohance Lifesciences Limited — Updates, 11-09-2025: General Updates
11-09-2025 | 06:09 pm
11-09-2025 | 06:09 pm
Cohance Lifesciences' API facility completed a USFDA cGMP audit with zero Form 483 observations. This successful inspection highlights robust quality standards, ensuring continued supply of high-quality pharmaceutical products for global markets.
No comments yet. Be the first to comment!
